Changes in ctDNA can predict long-term outcomes in certain patients with metastatic CRC on immune checkpoint inhibitors.

Programmes around education and health are expected to be especially hard hit by the cutting of international aid from 0.5 to 0.3 per cent of Gross National Income ...

MOMA-341 is being developed as a monotherapy and in combination with chemotherapy or immunotherapy for the treatment of advanced or metastatic solid tumors that exhibit high microsatellite instability ...